The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Parkinson’s Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Second consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324625.00404.15 · Cited by 3,140
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., Mollenhauer, B., Müller, U., Nilsson, C., Whitwell, J. L., et al. (2017) · Movement Disorders · doi:10.1002/mds.26987 · Cited by 2,359
Criteria for the diagnosis of corticobasal degeneration
Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., Boxer, A. L., Dickson, D. W., Grossman, M., Hallett, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0fd1 · Cited by 1,904
Self-citationPharmacological Treatment of Parkinson Disease: A Review
Connolly, B. S., & Lang, A. E. (2014) · JAMA · doi:10.1001/jama.2014.3654 · Cited by 1,498
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445
Fox, S. H., Katzenschlager, R., Lim, S., Barton, B., de Bie, R. M. A., Seppi, K., Coelho, M., Sampaio, C., & on behalf of the Movement Disorder Society Evidence‐Based Medicine Committee (2018) · Movement Disorders · doi:10.1002/mds.27372 · Cited by 1,002
Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis
Rizzo, G., Copetti, M., Arcuti, S., Martino, D., Fontana, A., & Logroscino, G. (2016) · Neurology · doi:10.1212/wnl.0000000000002350 · Cited by 870
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859
Olanow, C. W., Kieburtz, K., Odin, P., Espay, A. J., Standaert, D. G., Fernandez, H. H., Vanagunas, A., Othman, A. A., Widnell, K. L., Robieson, W. Z., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70293-x · Cited by 716
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges
Williams, D. R., & Lees, A. J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70042-0 · Cited by 650
Multiple system atrophy--the nature of the beast.
Quinn, N. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.suppl.78 · Cited by 644
The Synucleinopathies: Twenty Years On
Goedert, M., Jakes, R., & Spillantini, M. G. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179005 · Cited by 569
The genetics of Parkinson disease
Deng, H., Wang, P., & Jankovic, J. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.12.007 · Cited by 530
Cilia, R., Akpalu, A., Sarfo, F. S., Cham, M., Amboni, M., Cereda, E., Fabbri, M., Adjei, P., Akassi, J., Bonetti, A., et al. (2014) · Brain · doi:10.1093/brain/awu195 · Cited by 339
Nutt, J. G., Woodward, W. R., Beckner, R. M., Stone, C. K., Berggren, K., Carter, J. H., Gancher, S. T., Hammerstad, J. P., & Gordin, A. (1994) · Neurology · doi:10.1212/wnl.44.5.913 · Cited by 247
Duration of amantadine benefit on dyskinesia of severe Parkinson's disease.
Thomas, A., Iacono, D., Luciano, A. L., Armellino, K., Iorio, A. D., & ONOFRJ, M. C. (2004) · PubMed Central · Cited by 246
Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia
Cury, R. G., Fraix, V., Castrioto, A., Pérez Fernández, M. A., Krack, P., Chabardes, S., Seigneuret, E., Alho, E. J. L., Benabid, A.-L., & Moro, E. (2017) · Neurology · doi:10.1212/wnl.0000000000004295 · Cited by 246
Red flags for multiple system atrophy
Köllensperger, M., Geser, F., Seppi, K., Stampfer‐Kountchev, M., Sawires, M., Scherfler, C., Boesch, S., Mueller, J., Koukouni, V., Quinn, N., et al. (2008) · Movement Disorders · doi:10.1002/mds.21992 · Cited by 244
Hauser, R. A., Hsu, A., Kell, S., Espay, A. J., Sethi, K., Stacy, M., Ondo, W., O'Connell, M., & Gupta, S. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70025-5 · Cited by 210
Evolving basic, pathological and clinical concepts in PD
Kalia, L. V., & Lang, A. E. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.249 · Cited by 206
An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines
Olanow, C. W., & Koller, W. C. (1998) · Neurology · doi:10.1212/wnl.50.3_suppl_3.s1 · Cited by 203
Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease
Santos-García, D., & de la Fuente-Fernández, R. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.07.005 · Cited by 164
Ba, F., & Martin, W. R. W. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.11.007 · Cited by 160
Differentiating vascular parkinsonism from idiopathic Parkinson's disease: A systematic review
Kalra, S., Grosset, D. G., & Benamer, H. T. S. (2010) · Movement Disorders · doi:10.1002/mds.22937 · Cited by 141
Deep brain stimulation in Parkinson’s disease: meta-analysis of randomized controlled trials
Perestelo‐Pérez, L., Rivero‐Santana, A., Pérez-Ramos, J., Serrano-Pérez, P., Panetta, J. C., & Hilarión, P. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7254-6 · Cited by 134
Vascular P arkinsonism: D econstructing a S yndrome
Vizcarra, J. A., Lang, A. E., Sethi, K. D., & Espay, A. J. (2015) · Movement Disorders · doi:10.1002/mds.26263 · Cited by 121
Molecular imaging of dopamine transporters
Brooks, D. J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2015.12.009 · Cited by 114
The Nonmotor Features of Parkinson's Disease
Titova, N., Qamar, M. A., & Chaudhuri, К. R. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.02.016 · Cited by 96
Arguing against the proposed definition changes of PD
Boeve, B. F., Dickson, D. W., Duda, J. E., Ferman, T. J., Galasko, D. R., Galvin, J. E., Goldman, J. G., Growdon, J. H., Hurtig, H. I., Kaufer, D., et al. (2016) · Movement Disorders · doi:10.1002/mds.26721 · Cited by 76
Isaacson, S., Fisher, S., Gupta, F., Hermanowicz, N. S., Kremens, D. E., Lew, M., MAREK, K. L., Pahwa, R., Russell, D., & Seibyl, J. P. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1256205 · Cited by 45
Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease
Brod, L. S., Aldred, J. L., & Nutt, J. G. (2012) · Movement Disorders · doi:10.1002/mds.24998 · Cited by 41
Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson's Disease
Deeb, W., Spears, C. C., Opri, E., Molina, R., Martínez-Ramírez, D., Gunduz, A., Hess, C. W., Okun, M. S., & Almeida, L. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1601893 · Cited by 31
Extended-release oral capsule of carbidopa–levodopa in Parkinson disease
Margolesky, J. H., & Singer, C. (2017) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285617737728 · Cited by 29
Nonmotor symptoms and Parkinson disease in United States farmers and spouses
Shrestha, S., Kamel, F., Umbach, D. M., Freeman, L. E. B., Koutros, S., Alavanja, M. C. R., Sandler, D. P., & Chen, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185510 · Cited by 20
Paik, J., & Keam, S. J. (2018) · CNS Drugs · doi:10.1007/s40263-018-0552-2 · Cited by 20
Dyskinesias and levodopa therapy: why wait?
Matarazzo, M., Pérez‐Soriano, A., & Stoessl, A. J. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1856-6 · Cited by 17
Carbidopa levodopa enteral suspension
Seeberger, L., & Hauser, R. A. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1111336 · Cited by 16
Rodriguez‐Porcel, F. E., Jamali, S., Duker, A. P., & Espay, A. J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1120160 · Cited by 13
Julius, A., & Longfellow, K. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.03.002 · Cited by 12
All My Husband Needed Was a Good Physical Examination
Zimmerman, S. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.7183 · Cited by 3
Cited by
Molecular mechanisms of ferroptosis and their involvement in brain diseases
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402
Deep 1D-Convnet for accurate Parkinson disease detection and severity prediction from gait
El Maachi, I., Bilodeau, G.-A., & Bouachir, W. (2020) · Expert Systems with Applications · doi:10.1016/j.eswa.2019.113075 · Cited by 289
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101
Yan, L., Guo, M.-S., Zhang, Y., Yu, L., Wu, J.-M., Tang, Y., Ai, W., Zhu, F.-D., Law, B. Y.-K., Chen, Q., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5288698 · Cited by 97
Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
Stanga, S., Caretto, A., Boido, M., & Vercelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103719 · Cited by 90
Metadata
- Authors
- Reich, S. G., & Savitt, J. M.
- Venue
- Medical Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 103
- Issue
- 2
- Pages
- 337-350
- ISSN
- 0025-7125 (ISSN-L)
- OpenAlex
- W4242460813
- Cited by
- 483
- References
- 42
- FWCI
- 16.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.